{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:29:29Z","timestamp":1792373369951,"version":"4.4.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"crossref","award":["CBB-APQ-00819-12"],"award-info":[{"award-number":["CBB-APQ-00819-12"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"crossref","award":["CBB-APQ-01778-2014"],"award-info":[{"award-number":["CBB-APQ-01778-2014"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["APQ-482976\/2012-8"],"award-info":[{"award-number":["APQ-482976\/2012-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["APQ-488237\/2013-0"],"award-info":[{"award-number":["APQ-488237\/2013-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["APQ-467640\/2014-9"],"award-info":[{"award-number":["APQ-467640\/2014-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.molimm.2018.12.025","type":"journal-article","created":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T12:31:31Z","timestamp":1545913891000},"page":"108-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection"],"prefix":"10.1016","volume":"106","author":[{"given":"Patr\u00edcia A.F.","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela P.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edvian T.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourena E.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds T.O.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda F.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grasiele S.V.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora V.C.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Ludolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawidson A.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele A.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Ch\u00e1vez-Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo S.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexsandro S.","family":"Galdino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana C.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Menezes-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio L.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo A.F.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2018.12.025_bib0005","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fimmu.2014.00268","article-title":"Experimental validation of multi-epitope peptides including promising MHC class I- and II-restricted epitopes of four known Leishmania infantum proteins","volume":"5","author":"Agallou","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1756-3305-7-61","article-title":"LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4+ and CD8+) as well as a reduction of parasitism after challenge with leishmania infantum plus salivary gland of lutzomyia longipalpis","volume":"7","author":"Aguiar-Soares","year":"2014","journal-title":"Parasit. Vectors."},{"key":"10.1016\/j.molimm.2018.12.025_bib0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.vaccine.2008.10.013","article-title":"DNA based vaccination with a cocktail of plasmids encoding immunodominant leishmania major antigens confers full protection in BALB\/c mice","volume":"27","author":"Ahmed","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2018.12.025_bib0020","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molimm.2016.12.022","article-title":"Immunization with leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in BALB\/c mice","volume":"82","author":"Amit","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fimmu.2017.00227","article-title":"Leishmania donovani nucleoside hydrolase (NH36) domains induce T-cell cytokine responses in human visceral leishmaniasis","volume":"8","author":"Barbosa-Santos","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2005.05.028","article-title":"Pulmonary DNA vaccination:concepts, possibilities and perspectives","volume":"107","author":"Bivas-Benita","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.molimm.2018.12.025_bib0035","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/CVI.05660-11","article-title":"Killed but metabolically active Leishmania infantum as a novel whole-cell vaccine for visceral leishmaniasis","volume":"19","author":"Bruhn","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/pim.12206","article-title":"Analysis of iron superoxide dismutase-encoding DNA vaccine on the evolution of the Leishmania amazonensis experimental infection","volume":"37","author":"Campos","year":"2015","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0045","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/IAI.69.6.4103-4108.2001","article-title":"Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease","volume":"69","author":"Campos-Neto","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2018.12.025_bib0050","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/infdis\/165.3.535","article-title":"Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi","volume":"165","author":"Carvalho","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2018.12.025_bib0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fimmu.2014.00213","article-title":"Genetically modified organisms and visceral leishmaniasis","volume":"5","author":"Chhajer","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0060","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2018.12.025_bib0065","doi-asserted-by":"crossref","first-page":"e1430","DOI":"10.1371\/journal.pntd.0001430","article-title":"Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach","volume":"6","author":"Coelho","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2018.12.025_bib0070","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/IAI.70.8.4215-4225.2002","article-title":"Immunization with a polyprotein vaccine consisting of the T-cell antigens thiol-specific antioxidant, leishmania major stress-inducible protein 1, and leishmania elongation initiation factor protects against leishmaniasis","volume":"70","author":"Coler","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2018.12.025_bib0075","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a recombinant polyprotein vaccine that protects against visceral leishmaniasis by elicitation of CD4+ T cells","volume":"75","author":"Coler","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2018.12.025_bib0080","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1017\/S0031182015000724","article-title":"Phage-fused epitopes from Leishmania infantum used as immunogenic vaccines confer partial protection against Leishmania amazonensis infection","volume":"142","author":"Costa","year":"2015","journal-title":"Parasitology"},{"key":"10.1016\/j.molimm.2018.12.025_bib0085","doi-asserted-by":"crossref","first-page":"e3091","DOI":"10.1371\/journal.pntd.0003091","article-title":"Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection","volume":"8","author":"Das","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2018.12.025_bib0090","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.exppara.2015.12.002","article-title":"Leptin induces the phagocytosis and protective immune response in Leishmania donovani infected THP-1 cell line and human PBMCs","volume":"160","author":"Dayakar","year":"2016","journal-title":"Exp. Parasitol."},{"issue":"17","key":"10.1016\/j.molimm.2018.12.025_bib0095","article-title":"Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis","volume":"S0008-8749","author":"Dias","year":"2017","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0100","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3389\/fimmu.2017.01763","article-title":"Identification of potential MHC class-II-restricted epitopes derived from Leishmania donovani antigens by reverse vaccinology and evaluation of their CD4+ T-cell responsiveness against visceral leishmaniasis","volume":"8","author":"Dikhit","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.molimm.2016.06.014","article-title":"A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection","volume":"76","author":"Duarte","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbrc.2016.07.097","article-title":"Effects of different ligands on epidermal growth factor receptor (EGFR) nuclear translocation","volume":"478","author":"Faria","year":"2016","journal-title":"Bioch. Biop. Res. Commun."},{"key":"10.1016\/j.molimm.2018.12.025_bib0115","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1051\/vetres:2005033","article-title":"Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis","volume":"36","author":"Fujiwara","year":"2005","journal-title":"Vet. Res."},{"key":"10.1016\/j.molimm.2018.12.025_bib0120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fimmu.2014.00241","article-title":"Biomarkers of safety and immune protection for genetically modified live attenuated Leishmania vaccines against visceral leishmaniasis - discovery and implications","volume":"5","author":"Gannavaram","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fimmu.2016.00187","article-title":"Modulation of innate immune mechanisms to enhance Leishmaniavaccine-induced immunity: role of coinhibitory molecules","volume":"7","author":"Gannavaram","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0130","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0463.2012.02968.x","article-title":"Enhancement of immune response induced by DNA vaccine cocktail expressing complete LACK and TSA genes against Leishmania major","volume":"121","author":"Ghaffarifar","year":"2013","journal-title":"APMIS"},{"key":"10.1016\/j.molimm.2018.12.025_bib0135","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4269\/ajtmh.2009.80.566","article-title":"Evaluation of leishmanin skin test in Indian visceral leishmaniasis","volume":"80","author":"Gidwani","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.molimm.2018.12.025_bib0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"issue":"March 5","key":"10.1016\/j.molimm.2018.12.025_bib0145","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/pmic.200600725","article-title":"Proteomic approach for identification and characterization of novel immunostimulatory proteinsfrom soluble antigens of Leishmania donovani promastigotes","volume":"7","author":"Gupta","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.molimm.2018.12.025_bib0150","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/4000","article-title":"Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection","volume":"4","author":"Gurunathan","year":"1998","journal-title":"Nat. Med."},{"issue":"August (8)","key":"10.1016\/j.molimm.2018.12.025_bib0155","article-title":"Identification of leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis","volume":"18;12","author":"Jamal","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2018.12.025_bib0160","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s12639-014-0574-8","article-title":"The role of montanide ISA 70 as an adjuvant in immune responses against leishmania major induced by thiol-specific antioxidant-based protein vaccine","volume":"40","author":"Khabazzadeh","year":"2016","journal-title":"J. Parasit. Dis."},{"key":"10.1016\/j.molimm.2018.12.025_bib0165","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fimmu.2012.00251","article-title":"Immunobiology of visceral leishmaniasis","volume":"3","author":"Kumar","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/pim.12315","article-title":"DNA vaccine against visceral leishmaniasis: a promising approach for prevention and control","volume":"38","author":"Kumar","year":"2016","journal-title":"Parasite Immunol."},{"issue":"April4","key":"10.1016\/j.molimm.2018.12.025_bib0175","doi-asserted-by":"crossref","first-page":"e2764","DOI":"10.1371\/journal.pntd.0002764","article-title":"Identification of differentially expressed proteins from Leishmania amazonensis associated with the loss of virulence of the parasites","volume":"3;8","author":"Magalh\u00e3es","year":"2014","journal-title":"PLoS Negl. Trop Dis."},{"key":"10.1016\/j.molimm.2018.12.025_bib0180","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12359","article-title":"A recombinant chimeric protein composed of human and mice-specific CD4+and CD8+ T-cell epitopes protects against visceral leishmaniasis","volume":"39","author":"Martins","year":"2017","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0185","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/pim.12310","article-title":"Codelivery of DNA vaccination encoding LeIF gene and IL-12 increases protection against Leishmania major infection in BALB\/c mice","volume":"38","author":"Maspi","year":"2016","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0190","first-page":"267","article-title":"DNA vaccination with a plasmid encoding LACK-TSA fusion against Leishmania major infection in BALB\/c mice","volume":"39","author":"Maspi","year":"2017","journal-title":"Malays. J. Pathol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014644","article-title":"Potency, efficacy and durability of DNA\/DNA, DNA\/protein and protein\/protein based vaccination using gp63 against Leishmania donovani in BALB\/c mice","volume":"6","author":"Mazumder","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2018.12.025_bib0200","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/IAI.69.8.4719-4725.2001","article-title":"Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis","volume":"69","author":"Melby","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2018.12.025_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms19010129","article-title":"Small myristoylated protein-3, identified as a potential virulence factor in Leishmania amazonensis, proves to be a protective antigen against visceral leishmaniasis","volume":"19","author":"Oliveira","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molimm.2018.12.025_bib0210","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2008.01.023","article-title":"Vaccines for leishmaniasis in the fore coming 25 years","volume":"26","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2018.12.025_bib0215","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1128\/IAI.71.5.2924-2926.2003","article-title":"Th1 cell development induced by cysteine proteinases A and B in localized cutaneous Leishmaniasis due to Leishmania guyanensis","volume":"71","author":"Pascalis","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2018.12.025_bib0220","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-3083.2005.01686.x","article-title":"Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome","volume":"62","author":"Peruhype-Magalh\u00e3es","year":"2005","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: A 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"17","key":"10.1016\/j.molimm.2018.12.025_bib0230","first-page":"30184","article-title":"Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis","volume":"S0171-2985","author":"Portela","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.molimm.2018.12.025_bib0235","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1016\/j.vaccine.2006.01.030","article-title":"Comparison of potential protection induced by three vaccination strategies (DNA\/DNA, Protein\/Protein and DNA\/Protein) againstLeishmania major infection using Signal Peptidase type I in BALB\/c mice","volume":"24","author":"Rafati","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2018.12.025_bib0240","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1586\/14760584.2016.1105135","article-title":"Leishmaniavaccine development: exploiting the host-vector-parasite interface","volume":"15","author":"Reed","year":"2016","journal-title":"Expert Rev. Vaccines"},{"issue":"August 111","key":"10.1016\/j.molimm.2018.12.025_bib0245","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cyto.2018.08.019","article-title":"A leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis","volume":"21","author":"Ribeiro","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.molimm.2018.12.025_bib0250","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2014.00272","article-title":"Immunotherapy and immunochemotherapy in visceral leishmaniasis: promising treatments for this neglected disease","volume":"5","author":"Roatt","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0255","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.vaccine.2014.01.024","article-title":"Immunization with the Leishmania infantum recombinant cyclophilin protein 1 confers partial protection to subsequent parasite infection and generates specific memory T cells","volume":"32","author":"Santos-Gomes","year":"2014","journal-title":"Vaccine"},{"issue":"October 44","key":"10.1016\/j.molimm.2018.12.025_bib0260","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1016\/j.vaccine.2016.09.016","article-title":"Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant","volume":"17;34","author":"Schaut","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2018.12.025_bib0265","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/631460","article-title":"Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites","volume":"2012","author":"Selvapandiyan","year":"2012","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.molimm.2018.12.025_bib0270","doi-asserted-by":"crossref","first-page":"e1874","DOI":"10.1371\/journal.pntd.0001874","article-title":"Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis","volume":"6","author":"Singh","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2018.12.025_bib0275","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13071-016-1553-y","article-title":"Possibilities and challenges for developing a successful vaccine for leishmaniasis","volume":"9","author":"Srivastava","year":"2016","journal-title":"Parasit. Vectors."},{"key":"10.1016\/j.molimm.2018.12.025_bib0280","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14656566.2013.755515","article-title":"Leishmaniasis: an update of current pharmacotherapy","volume":"14","author":"Sundar","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.molimm.2018.12.025_bib0285","first-page":"1","article-title":"Chemotherapeutics of visceral leishmaniasis: present and future developments","volume":"7","author":"Sundar","year":"2017","journal-title":"Parasitology"},{"key":"10.1016\/j.molimm.2018.12.025_bib0290","doi-asserted-by":"crossref","first-page":"e8974","DOI":"10.5812\/jjm.8974","article-title":"Th1 platform immune responses against Leishmania major induced by thiol-specific antioxidant-based DNA vaccines","volume":"7","author":"Tabatabaie","year":"2014","journal-title":"Jundishapur J. Microbiol."},{"key":"10.1016\/j.molimm.2018.12.025_bib0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006082","article-title":"Canine visceral leishmaniasis: diagnosis and management of the reservoir living among us","volume":"12","author":"Travi","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2018.12.025_bib0300","series-title":"Leishmaniasis","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.molimm.2018.12.025_bib0305","doi-asserted-by":"crossref","first-page":"e2751","DOI":"10.1371\/journal.pntd.0002751","article-title":"Enhanced protective efficacy of nonpathogenic recombinant Leishmania tarentolaeexpressing cysteine proteinases combined with a sand fly salivary antigen","volume":"8","author":"Zahedifard","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2018.12.025_bib0310","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.micinf.2007.05.012","article-title":"Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections","volume":"9","author":"Zanin","year":"2007","journal-title":"Microbes Infect."},{"key":"10.1016\/j.molimm.2018.12.025_bib0315","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijmm.2007.07.011","article-title":"CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections","volume":"298","author":"Zimmermann","year":"2008","journal-title":"Int. J. Med. Microbiol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018310563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018310563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:30:28Z","timestamp":1758979828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589018310563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":63,"alternative-id":["S0161589018310563"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2018.12.025","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2018.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}